SHOUCHENG (00697) invests in Cheng optical technology, effectively empowering its team building and product research and development with iterative upgrades.

SHOUCHENG (00697) announced that its subsidiary Shoucheng Capital has recently invested in Chengguang Optical Technology (Nantong) Co., Ltd., a company managed by the group's wholly-owned subsidiary. This investment will effectively empower the invested company's team building and product research and development, helping it to continuously build core technological barriers. Chengguang Optical is a high-tech enterprise focused on developing unlabeled super-resolution imaging equipment for live cells based on optical diffraction tomography (ODT) technology. The company has already partnered with leading global manufacturers and is an innovative force in breaking the international monopoly of high-end optical instruments in China. This investment will provide Chengguang Optical with greater momentum in team building and core industry research and development, further accelerating the industrialization of technology and building core technological barriers and market competitive advantages. In the future, the group will continue to steadily increase its investment in cutting-edge technology. With the support of capital empowerment and industrial synergy advantages, it will help the invested companies accelerate the industrialization of research results, contribute to the upgrade of life science research and medical health industry, and further promote the thriving development of high-end medical equipment and life science instruments industry.